Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients

MJ Joyner, KA Bruno, SA Klassen, KL Kunze… - Mayo Clinic …, 2020 - Elsevier
… of key safety indicators in 5000 patients transfused with COVID-19 convalescent plasma …
safe in hospitalized adults with COVID-19. Because an additional 15,000 hospitalized patients

Efficacy and safety of COVID-19 convalescent plasma in hospitalized patients: a randomized clinical trial

…, JS Hochman, L Pirofski, C COVID… - JAMA internal …, 2022 - jamanetwork.com
… , 14 -19 despite showing … in hospitalized patients with COVID-19 in NYC and Long Island,
New York, requiring noninvasive oxygen supplementation. When the spring 2020 COVID-19

Efficacy and safety of remdesivir in hospitalized Covid19 patients: systematic review and meta‐analysis including network meta‐analysis

HK Elsawah, MA Elsokary, MS Abdallah… - Reviews in medical …, 2021 - Wiley Online Library
… to prioritise remdesivir for use in hospitalized patients with Covid-19 who require low-flow …
given for 5 days or until hospital discharge, except for patients requiring high-flow oxygen or …

Early safety indicators of COVID-19 convalescent plasma in 5000 patients

MJ Joyner, RS Wright, DL Fairweather… - The Journal of …, 2020 - Am Soc Clin Investig
… that transfusion of convalescent plasma is safe in hospitalized patients with COVID-19. … ,
and more than 5000 hospitalized patients with COVID-19 were transfused with convalescent …

… standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial

…, B Dehali, HEP-COVID Investigators - JAMA internal …, 2021 - jamanetwork.com
Hospitalized patients with COVID-19 are at risk for venous and arterial thromboembolism
and death. Optimal thromboprophylaxis dosing in high-risk patients is unknown. …

Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis

MT Angamo, MA Mohammed, GM Peterson - Infection, 2022 - Springer
patients hospitalised with moderate-to-severe COVID-19 and compared the effectiveness
and … included hospitalised patients aged 12 years or over with moderate-to-severe COVID19

[PDF][PDF] Communicating effectively with hospitalized patients and families during the COVID19 pandemic

G Rosenbluth, BP Good, KP Litterer… - Journal of hospital …, 2020 - cdn.mdedge.com
… with the overwhelming threat of COVID-19 in the equation. My … Now, amid the COVID-19
pandemic, we have heard that pa… concern of just being safe in the hospital,” reported a member …

[HTML][HTML] Efficacy and safety of molnupiravir for COVID-19 patients

M Fatima, S Azeem, J Saeed, A Shahid… - European Journal of …, 2022 - ncbi.nlm.nih.gov
… only be effective in some subgroups of hospitalized patients; therefore, publication of the …
the use of molnupiravir in non-hospitalized patients with COVID-19. Further research should be …

Development and validation of predictive models for COVID-19 outcomes in a safety-net hospital population

B Hao, Y Hu, S Sotudian, Z Zad… - Journal of the …, 2022 - academic.oup.com
… considered admitted patients. In addition to the features utilized in the hospitalization model,
… , and we excluded symptoms since severe COVID-19 patients were less likely to describe …

[HTML][HTML] Characterization of critically ill COVID-19 patients at a brooklyn safety-net hospital

S Capone, S Abramyan, B Ross, J Rosenberg… - Cureus, 2020 - ncbi.nlm.nih.gov
… 82.4% of our critically ill patients identified as African American or Hispanic. … COVID-19
patients at our community safety-net hospital in Brooklyn, New York, with the most diverse patient